Reducing Infusion Failure: A Pharmacologic Approach - A Review

Journal of Intravenous Nursing

Volumn 19, Issue 2, 1996, Pages 89-XI

  Wright, Alex ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

INFUSION FLUID;

CLINICAL FEATURE; EXTRAVASATION; HUMAN; INCIDENCE; INTRAVENOUS DRUG ADMINISTRATION; PATIENT CARE; PHLEBITIS; REVIEW;

ADULT; CHILD; EXTRAVASATION OF DIAGNOSTIC AND THERAPEUTIC MATERIALS; HUMANS; INFUSIONS, INTRAVENOUS; RISK FACTORS; THROMBOPHLEBITIS;

EID: 0029958992     PISSN: 08965846     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (93)

1. Streckfuss BL. Pediatric IV Care. National Intravenous Therapy Association 1985;8:75-82.
2. Wright A, Hecker JF, Lewis GBH. Use of transdermal glyceryl trinitrate to reduce failure of intravenous infusions due to phlebitis and extravasation. Lancet 1985;2:1148-1150.
3. Lewis GBH, Hecker JF. Changes in local venous tone in response to infusions of saline and dextrose solutions. Anaesth Intensive Care 1984;12:27-32.
4. Turnidge J. Hazards of peripheral intravenous lines. Med J Aust 1984;7:37-40.
5. Millam DA. Managing complications of I.V. therapy. Nursing 88 1988;18:34-42.
6. Feldstein A. Detect phlebitis and infiltration before they harm your patient. Nursing 86 1986;16:44-47.
7. MacCara ME. Extravasation: a hazard of intravenous therapy. Drug Intelligence and Clinical Pharmacy 1983;17:713-717.
8. Tager IB, Ginsberg MB, Ellis SE, Walsh NE, Dupont I, Simchen E, Faich GA. An epidemiologic study of the risks associated with peripheral intravenous catheters. Am J Epidemiol 1983;118:839-851.
9. Tully JL, Friedland GH, Baldini LM, Goldmann DA. Complications of intravenous therapy with steel needles and teflon catheters. Am J Med 1981;70:702-706.
10. Brown GA. Infusion thrombophlebitis. British Journal of Clinical Practice 1970;24:197-200.
11. Stephen M, Lowenthal J, Wong J, Benn R. Complications of intravenous therapy. Medical Journal of Australia 1976;2: 557-560.
12. Collin J, Collin C, Constable FL, Johnston IDA. Infusion thrombophlebitis and infection with various cannulas. Lancet 1975;150-153.
13. Page BH, Raine G, Jones PF. Thrombophlebitis following intravenous infusions. Lancet 1971;2:778.
14. M.R.C. Trial. Thrombophlebitis following intravenous infusions trial of plastic and red rubber giving sets. Lancet 1957;2:595-597.
15. Nelson DB, Garland JS. The natural history of teflon catheter-associated phlebitis in children. Am J Dis Child 1987; 141:1090-1092.
16. Tobin CR. The teflon intravenous catheter: incidence of phlebitis and duration of catheter life in the neonatal patient. J Obstet Gynecol Neonat Nurs 1988;Jan/Feb:35-42.
17. Khawaja HT, Campbell MJ, Weaver PC. Effect of transdermal glyceryl trinitrate on the survival of peripheral intravenous infusions: a double-blind prospective clinical study. British Journal of Surgery 1988;75:1212-1215.
18. Falchuk KH, Peterson L, McNeil BJ. Microparticulate-induced phlebitis: its prevention by in-line filtration. New Engl J Med 1985;312:78-82.
19. Lewis GBH, Hecker JF. Infusion thrombophlebitis. British Journal of Anaeathesia 1985;57:220-233.
20. DeLuca PP, Rapp RP, Bivins B, McKean HE, Griffen WO. Filtration and infusion phlebitis: A double-blind prospective clinical study. American Journal of Hospital Pharmacy 1975;32: 1001-1007.
21. Fonkalsrud EW, Murphy J, Smith FG. Effect of pH in glucose infusions on development of thrombophlebitis. Journal of Surgical Research 1968;8:539-543.
22. Eremin O, Marshall V. Complications of intravenous therapy: reduction by buffering of intravenous fluid preparation. Medical Journal of Australia 1977;2:528-531.
23. Woodhouse CRJ. Infusion thrombophlebitis: histological and clinical features. Annals of the Royal College of Surgeons of England 1980;62:364-368.
24. Simmons CA, Burdick BS, Schaub RG. Heparin inhibits fibrin but not leukocytes in a model of deep-vein thrombosis. Journal of Surgical Research 1987;43:468-475.
25. Kay I, Roberts SS. Infusions and phlebitis. Am J Nurs 1967;67:2081.
26. Wright A. Nursing implications of low-dose heparin to infusate to improve infusion site survival in children. Australian Critical Care 1993;6:10-13.
27. Maki DG, Goldmann DA, Rhame FS. Infection control in intravenous therapy. Ann Intern Med 1973;79:867-887.
28. Ross SA. Infusion phlebitis. Nurs Res 1985;21:313-318.
29. Curry JT, Zallen RD. Reduction of thrombophlebitis associated with indwelling catheters. Journal of Oral Surgery 1973;31:636.
30. Maki DG. Infections associated with intravascular lines. In: Remington JS, Swartz MN, eds. Current Clinical Topics in Infectious Diseases. Vol. 3. New York: McGraw Hill, 1982:309-363.
31. Elfving G, Saikku K. Effect of pH on the incidence of infusion thrombophlebitis. Lancet 1966;i:953.
32. Fonkalsrud EW, Pederson BM, Murphy J. Reduction of infusion thrombophlebitis with buffered glucose solution. Surgery 1968;63:280-284.
33. Hessov I, Bojsen-Moller B. Experimental infusion thrombophlebitis. Importance of the pH of glucose solutions. European Journal of Intensive Care Medicine 1976;2:103-105.
34. 34: Bolton-Carter JF, Milne EH, Whittet TD. Thrombophlebitis following intravenous infusions. Lancet 1952;2:660.
35. Tse RL, Lee MW. pH of infusion fluids A predisposing factor in thrombophlebitis. JAMA 1971;215:642.
36. Hecker JF, Duffy B, Fong T, Wyer M. Failure of intravenous infusions in neonates. Journal of Pediatrics and Child Health 1991;27:175-179.
37. Bivins BA, Rapp RP, DeLuca PP, McKean H, Griffen WO. Final inline filtration: a means of decreasing the incidence of infusion phlebitis. Surgery 1979;85:388-394.
38. Rypins EB, Johnson BH, Reder B, Sarfeh IJ, Shimoda K. Three-phase study of phlebitis in patients receiving peripheral intravenous hyperalimentation, Am J Surg 1990;159:222-225.
39. Allcutt DA, Lort D, McCollum CN. Final inline filtration for intravenous infusions: a prospective hospital study. British Journal of Surgery 1983;70:111-113.
40. Collin J, Tweedle DEF, Venables CW, Constable FL, Johnston IDA. Effect of a millipore filter on complications of intravenous infusions: a prospective clinical trial. BMJ 1973;4: 456-458.
41. Thayssen P, Kortegaard N, Winding O. Postinfusion phlebitis and in-line terminal membrane filtration. Danish Medical Bulletin 1977;24:160-162.
42. Ryan PB, Rapp BP, DeLuca PP, Griffen WO Jr., Clark JD, Cloys D. In-line final filtration - a method of minimizing contamination in intravenous therapy. Bulletin of the Parenteral Drug Association 1973;27:1-14.
43. Maddox RR, Rush DR, Rapp RP, Foster TS, Mazella V, McKean HE. Double-blind study to investigate methods to prevent cephalothin-induced phlebitis. American Journal of Hospital Pharmacy 1977;34:29-34.
44. Evans WE, Barker LF, Simone JV. Double-blind evaluation of 5 um final filtration to reduce postinfusion phlebitis. American Journal of Hospital Pharmacy 1976;33:1160-1163.
45. Rusho WJ, Bair JN. Effect of filtration on complications of postoperative intravenous therapy. American Journal of Hospital Pharmacy 1979;36:1355-1356.
46. Adams SD, Killien M, Larson E. In-line filtration and infusion phlebitis. Heart and Lung 1986;15:134-140.
47. Querica RA, Hills SW, Klimek JH, McLaughlin JC, Nightingale CH, Drezner AD, Sigman R. Bacteriologic contamination of intravenous delivery systems in an intensive care unit. Am J Med 1986;80:364-368.
48. Simmons BP, Hooton TM, Wong ES. Guidelines for prevention of intravascular infections. Infection Control and Hospital Epidemiology 1982;3:61-67.
49. Bulter LD, Munson JM, DeLuca PP. Effect of inline filtration on the potency of low dose drugs. American Journal of Hospital Pharmacy 1980;37:935-956.
50. DeLuca PP. Binding of drugs to inline filters (letter). American Journal of Hospital Pharmacy 1979;36:151-154.
51. Khawaja HT, Williams JD, Weaver PC. Transdermal glyceryl trinitrate to allow peripheral total parenteral nutrition: a double-blind placebo controlled feasibility study. Journal of the Royal Society of Medicine 1991;84:69-72.
52. Alpan G, Eyal F, Spinger C, Glick B, Goder K, Armon J. Heparinization of alimentation solutions administered through peripheral veins in premature infants: a controlled study. Pediatrics 1984;174:375-378.
53. Hecker JF. Local percutaneous glyceryl trinitrate does not prolong survival of peripheral infusions in neonates. Pediatric Review Communication 1990;5:51-54.
54. Ansel HC. Change in pH of infusion solutions upon mixing with blood. JAMA 1971;218:1052.
55. Bass J, Freeman JB, Makarewicz P, Sproule P, Fairfull-Smith R. Preventing superficial phlebitis during infusion of crystalloid solutions in surgical patients. Can J Surg 1985;28: 124-125.
56. Woodhouse CRJ. Movelat in the prophylaxis of infusion thrombophlebitis, BMJ 1979;2:454-455.
57. Sketch MH, Cale M, Mohiuddm SM, Booth RW. Use of percutaneously inserted venous catheters in coronary care units. Chest 1972;62:684-689.
58. Fonkalsrud EW, Carpenter K, Masuda JY, Beckerman JH. Prophylaxis against postinfusion phlebitis. Surgery, Gynecology and Obstetrics 1971;133:253-256.
59. Clark PB, Polak A, Hajnal J. A clinical trial of hydrocortisone in the prevention of transfusion thrombophlebitis. Post-graduate Medical Journal 1960;36:55-56.
60. Hecker JF, Fisk GC, Lewis GBH. Phlebitis and extravasation ("tissuing") with intravenous infusions. Med J Aust 1984; 140:658-660.
61. Reid I, Keane FBV, Monson JRT, Tanner WA. Thrombophlebitis following peripherally administered parenteral nutrition - a randomised clinical study of the effect of infusion additives. Surgery Research Communication 1990;9:69-77.
62. Messing B, Levere X, Rigaud D. Peripheral venous complications of a hyperosmolar nutritive mixture: the effect of heparin and hydrocortisone. A multicenter double-blind random study in 98 patients. Clinical Nutrition 1986;5:57-61.
63. Tanner WA, Delaney PV, Hennessy TP. The influence of heparin on intravenous infusions: a prospective study. British Journal of Surgery 1980;67:311-312.
64. Daniell HW. Heparin in the prevention of infusion phlebitis: a double-blind controlled study. JAMA 1973;226:1317-1321.
65. Wessler S, Rogers WR. Intermittent intravenous therapy: experience with a simple method for the administration of heparin and other drugs in 269 medical and surgical patients. New Engl J Med 1956;225:22-25.
66. Aburahma AF, Boland JP, Witsberger T. Diagnostic and therapeutic strategies of white clot syndrome. Am J Surg 1991; 162:175-179.
67. Aburahma AF, Malik FS, Boland JP. Heparin-induced thrombocytopenia with thrombotic complications. West Virginia Medical Journal 1992;88:95-100.
68. Potter C, Gill JC, Scott JP, McFarland JG. Heparin-induced thrombocytopenia in a child. Journal of Pediatrics 1992; 121:135-138.
69. Oriot D, Wolf M, Wood C, Brun P. Severe heparin-induced thrombocytopenia in a child with acute myocarditis. Archives of Pediatrics 1990;47:357-359.
70. Hastbacka J, Tammisto T. Hirudoid salva som forchyggande medel mot infusions thromboflebit: en Klinik undersokning met blindtest baserad pa bilaterala infusioner. Nordisk Medicine 1967;77:444.
71. Messing B. Infusion-related phlebitis. New Engl J Med 1985;312:1452.
72. Treas LS, Latinis-Bridges B. Efficacy of heparin in peripheral venous infusion in neonates. J Obstet Gynecol Neonat Nurs 1991;21:214-219.
73. Moclair AE, Hecker JF, Willson A, Bates IP. Prolonging the survival of peripheral infusion sites in neonates with low-dose heparin. International Journal of Pharmacy Practice 1992; August:198-201.
74. Wright A, Hecker JF, McDonald G. Effects of low-dose heparin on failure of intravenous infusions in children. Heart and Lung 1995;24:79-82.
75. Blair WF, Kilpatrick WC Jr., Saiki JH, Atler EJ. Extravasation of chemotherapeutic agents. Clin Orthop Rel Res 1980; 151:228-230.
76. Brown AS, Hoelzer DJ, Piercy SA. Skin necrosis from extravasation of intravenous fluids in children. Plastic and Reconstructive Surgery 1979;64:145-150.
77. Yosowitz P, Ekland DA, Shaw RC, Parsons RW. Peripheral intravenous infiltration necrosis. Ann Surg 1975;182:553-556.
78. Brismar B, Hardstedt C, Jacobson S. Reduction of catheter-associated thrombosis in parenteral nutrition by intravenous heparin therapy. Archives of Surgery 1982;117:1196-1199.
79. Rajani K, Goetzman BW, Wennberg RP. Effect of heparinization of fluids infused through an umbilical artery catheter on catheter patency and frequency of complications. Pediatrics 1973;63:552-556.
80. Ekre HPT, Fjellner BR, Hagermark O. Inhibition of complement dependent experimental inflammation in human skin by different heparin fractions. International Journal of Immuno-Pharmacology 1986;8:277-286.
81. Bowler SD, Smith SM, Lavercombe PS, Williams G. Heparin inhibits mast cell mediated acute allergic reactions in the lung and skin. Journal of Human Immunology 1988;79:9-11.
82. Laghipasini F, Pasqui AL, Ceccatelli L. Heparin inhibition of polymorphonuclear leukocyte activation in vitro. A possible pharmacologic approach to granulocyte mediated vascular damage. Thrombosis Research 1984;35:527-537.
83. Handler DA. Heparin and related molecules as future drugs in the control of atherosclerosis. In: Conference - Heparin and Related Dipolysaccharides. Oxford: Oxford University Press, 1988;2-9.
84. DiCorelto PE, Fox PL. Regulation of production of a platelet-derived growth factor-like protein in cultured bovine aortic endothelial cells. In: Third International Symposium on the Biology of the Vascular Endothelial Cell. Cambridge, MA: Massachusetts Institute of Technology, 1984;12.
85. Hiebert LM, Jaques LB. Heparin uptake on endothelium. Artery 1976;2:26-37.
86. Majack RA, Bornstein P. Heparin regulates the collagen phenotype of vascular smooth muscle cells: induced synthesis of an M, 60,000 collagen. Journal of Cell Biology 1985;100:613-619.
87. Maciag T. Angiogenesis. Progress in Hemostasis and Thrombosis 1984;7:167-182.
88. Thornton SC, Mueller SN, Levine EM. Human endothelial cells: use of heparin in cloning and long term serial cultivation. Science 1982;222:623-265.
89. Terranova VP, Diflorio R, Lyall RM. Human endothelial cells are chemotactic to endothelial cell growth factor and heparin. Journal of Cell Biology 1985;101:2330-2334.
90. Covey M, McLane C, Smith N, Matasic J, Holm K. Infection related to intravascular pressure monitoring: Effects of flush and tubing changes. Am J Infect Control 1988;16:206-213.
91. DeCock C, Vermeij P, Stijnen T. On the efficacy of low dose prednisolone and heparin sodium in the prevention of infusion thrombophlebitis: a double blind trial. Pharmaceutish Weekbl (Sci) 1984;6:88-90.
92. Schafermeyer RW. Prevention of phlebitis. JAMA 1974; 228:695-696.
93. Hecker JF. The potential for extending the survival of peripheral intravenous infusions. BMJ 1992;304:619-624.